Cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients undergoing elective thoracoscopic valve or (and) coronary artery bypass grafting. (2) Aged between 18 and 85 years. (3) Conscious, with stable vital signs, normal comprehension, no expressive disorders, and able to cooperate with treatment.
Exclusion criteria
Exclusion criteria: (1) Contraindications to TEAS, including scarring, skin damage, or infection at the irritation site, as well as the presence of implanted electronic devices such as pacemakers. (2) Presence of acute or chronic pain in the preoperative surgical area. (3) A confirmed diagnosis of severe dysfunction of the brain, liver, or kidneys. (4) Serious cardiac arrhythmias, including severe sinus bradycardia or class II or higher atrioventricular block. (5) Significantly abnormal coagulation function, severe immune system disorders, or infectious diseases. (6) Communication disorders resulting from severe central nervous system diseases. (7) History of addiction to analgesic medications. (8) Patients requiring conversion to open-chest surgery during the procedure. (9) Participation in other interventional studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute postoperative pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of chronic postoperative pain;Proportion of patients with neuropathic pain among patients with chronic postoperative pain;sleep quality;anxiety;Duration of mechanical ventilation;ICU stays;Total length of stay;Chest tube retention time;The proportion and dosage of postoperative rescue analgesia;Intraoperative anaesthetic dosage;postoperative pain; | — |
Countries
China
Contacts
Fujian Medical University Union Hospital